Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries

Journal of Clinical Epidemiology

Volumn 82, Issue , 2017, Pages 29-36.e6

  Ndounga Diakou, Lee Aymar ^a,b,c   Ntoumi, Francine ^a,d,e   Ravaud, Philippe ^b,c,f   Boutron, Isabelle ^b,c,f  

^a Fondation Congolaise pour la Recherche Médicale FCRM Faculté des sciences de la santé   (Democratic Republic Congo)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Marien Ngouabi University   (Democratic Republic Congo)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Epidemiology; Global burden of disease; High income countries; International collaboration; Low and middle income countries; Randomized controlled trials; Research implementation; Sub Saharan Africa

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME NURSING; AFRICA SOUTH OF THE SAHARA; BURDEN OF DISEASE; COCHRANE LIBRARY; DISABILITY; FUNDING; HEALTH STATUS INDICATOR; HIGH INCOME COUNTRY; HUMAN; LIFE; LOWER RESPIRATORY TRACT INFECTION; MALARIA; MEDLINE; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; COST OF ILLNESS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMICS; STATISTICS AND NUMERICAL DATA;

AFRICA SOUTH OF THE SAHARA; COST OF ILLNESS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85008319786     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.10.008     Document Type: Review

References (155)

1. [1] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
2. [2] Dalal, S., Beunza, J.J., Volmink, J., Adebamowo, C., Bajunirwe, F., Njelekela, M., et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 40 (2011), 885–901.
3. [3] Mensah, G.A., Roth, G.A., Sampson, U.K., Moran, A.E., Feigin, V.L., Forouzanfar, M.H., et al., GBD 2013 Mortality and Causes of Death collaborators. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc J Afr 26:2 Suppl 1 (2015), S6–S10.
4. [4] Schulz, K.F., Randomized controlled trials. Clin Obstet Gynecol 41:2 (1998), 245–256.
5. [5] Barreto, M.L., Health research in developing countries. BMJ, 339, 2009, b4846.
6. [6] Atani, M., Kabore, M.P., African Index Medicus: improving access to African health information. S Afr Fam Pract 49:2 (2007), 4–7.
7. [7] Glanville, J.M., Lefebvre, C., Miles, J.N., Camosso-Stefinovic, J., How to identify randomized controlled trials in MEDLINE: ten years on. J Med Libr Assoc 94 (2006), 130–136.
8. [8] Pienaar, E., Grobler, L., Busgeeth, K., Eisinga, A., Siegfried, N., Developing a geographic search filter to identify randomised controlled trials in Africa: finding the optimal balance between sensitivity and precision. Health Info Libr J 28 (2011), 210–215.
9. [9] Holmes, M.D., Dalal, S., Volmink, J., Adebamowo, C.A., Njelekela, M., Fawzi, W.W., et al. Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med, 7(5), 2010, e1000244.
10. [10] Connor, M.D., Walker, R., Modi, G., Warlow, C.P., Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurol 6 (2007), 269–278.
11. [11] Mbanya, J.C., Motala, A.A., Sobngwi, E., Assah, F.K., Enoru, S.T., Diabetes in sub-Saharan Africa. Lancet 375 (2010), 2254–2266.
12. [12] Isaakidis, P., Swingler, G.H., Pienaar, E., Volmink, J., Ioannidis, J.P., Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ, 324, 2002, 702.
13. [13] Swingler, G.H., Pillay, V., Pienaar, E.D., Ioannidis, J.P., International collaboration, funding and association with burden of disease in randomized controlled trials in Africa. Bull World Health Organ 83:7 (2005), 511–517.
14. [14] Lutje, V., Gerritsen, A., Siegfried, N., Randomized controlled trials of malaria intervention trials in Africa, 1948 to 2007: a descriptive analysis. Malar J, 10, 2011, 61.
15. [15] Zani, B., Pienaar, E.D., Oliver, J., Siegfried, N., Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register. PLoS One, 6, 2011, e28759.
16. [16] Siegfried, N., Clarke, M., Volmink, J., Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ, 331, 2005, 742.
17. [17] Emdin, C.A., Odutayo, A., Hsiao, A.J., Shakir, M., Hopewell, S., Rahimi, K., et al. Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials–ESORT). BMJ, 350, 2015, h117.
18. [18] Falagas, M.E., Bliziotis, I.A., Kondilis, B., Soteriades, E.S., Eighteen years of research on AIDS: contribution of and collaborations between different world regions. AIDS Res Hum Retroviruses 22 (2006), 1199–1205.
19. [19] Chersich, M.F., Blaauw, D., Dumbaugh, M., Penn-Kekana, L., Dhana, A., Thwala, S., et al. Local and foreign authorship of maternal health interventional research in low- and middle-income countries: systematic mapping of publications 2000-2012. Glob Health, 12(1), 2016, 35.
20. [20] Nordling, L., African nations vow to support science. Nature 465 (2010), 994–995.
21. [21] Heymann, D.L., Liu, J., Lillywhite, L., Partnerships, Not Parachutists, for Zika research. N Engl J Med 374 (2016), 1504–1505.
22. [22] Knottnerus, J.A., Tugwell, P., Rapprochement of research and practice. J Clin Epidemiol 67 (2014), 121–122.
23. [23] Lawoyin, T.O., Lawoyin, O.O., Translation of research into reality in sub-Saharan Africa. Lancet 381 (2013), 2146–2147.
24. [24] Kendrick, T., Hegarty, K., Glasziou, P., Interpreting research findings to guide treatment in practice. BMJ, 337, 2008, a1499.
25. [25] Siegfried, N., Clarke, M., Volmink, J., Van der, M.L., African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation than North American trials. PLoS One, 3, 2008, e3491.
26. [26] Smith, E., Hunt, M., Master, Z., Authorship ethics in global health research partnerships between researchers from low or middle income countries and high income countries. BMC Med Ethics, 15, 2014, 42.
27. [27] Binka, F., Editorial: north-south research collaborations: a move towards a true partnership?. Trop Med Int Health 10 (2005), 207–209.
28. [28] Rudan, I., Preventing inequity in international research. Science 319 (2008), 1336–1337.
29. [29] Chu, K.M., Jayaraman, S., Kyamanywa, P., Ntakiyiruta, G., Building research capacity in Africa: equity and global health collaborations. PLoS Med, 11(3), 2014, e1001612.
30. [30] Cohen, J., Balancing the collaboration equation. Science 288 (2000), 2155–2159.
31. [31] Whitworth, J.A., Kokwaro, G., Kinyanjui, S., Snewin, V.A., Tanner, M., Walport, M., et al. Strengthening capacity for health research in Africa. Lancet 372 (2008), 1590–1593.
32. [32] Kana, M.A., “Publish or perish” is good for African research. BMJ, 352, 2016, i121.
33. [33] Ruggeri, K., Disseminating health research in sub-Saharan Africa through journal partnerships. Lancet Glob Health 2:4 (2014), e193–e194.
34. [34] Nordling, L., Africa aims for research autonomy. Nature 520 (2015), 142–143.
35. [1] Abdallah, T.M., Elmardi, K.A., Elhassan, A.H., Omer, M.B., Elhag, M.S., Desogi, M.A., et al. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan. J Infect Dev Ctries 8 (2014), 611–615.
36. [2] Adam, M.B., Effectiveness trial of community-based I Choose Life-Africa human immunodeficiency virus prevention program in Kenya. Am J Trop Med Hyg 91 (2014), 645–648.
37. [3] Adegnika, A.A., Zinsou, J.F., Issifou, S., Ateba-Ngoa, U., Kassa, R.F., Feugap, E.N., et al. Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single-versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection. Antimicrob Agents Chemother 58 (2014), 2535–2540.
38. [4] Adeniyi, A.A., Odukogbe, A.A., Olayemi, A., Oladokun, O., Adeniji, A.O, Aimakhu, C.O., et al. Randomization of two dosing regimens of vaginal misoprostol for cervical ripening and labor induction in a low resource setting. Niger J Clin Pract 17:3 (2014), 287–291.
39. [5] Adjei, G.O., Goka, B.Q., Enweronu-Laryea, C.C., Rodrigues, O.P., Renner, L., Sulley, A.M., et al. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria. Malar J, 13, 2014, 369.
40. [6] Aebi, S., Gelber, S., Anderson, S.J., Láng, I., Robidoux, A., Martín, M., et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol 15 (2014), 156–163.
41. [7] Althabe, F., Belizan, J.M., McClure, E.M, Hemingway-Foday, J., Berrueta, M., Mazzoni, A., et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 385 (2015), 629–639.
42. [8] Anyachukwu, C.C., Onyeso, O.K.K., Efficacy of adjunct (laser) therapy to topical agents among Southern Nigerian acne vulgaris patients. Acupuncture Relat Therapies 2 (2014), 66–70.
43. [9] Ashley, E.A., Dhorda, M., Fairhurst, R.M., Amaratunga, C., Lim, P., Suon, S., et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371 (2014), 411–423.
44. [10] Ashorn, P., Alho, L., Ashorn, U., Cheung, Y.B., Dewey, K.G., Harjunmaa, U., et al. The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial. Am J Clin Nutr 101 (2015), 387–397.
45. [11] Awadzi, K., Opoku, N.O., Attah, S.K., Lazdins-Helds, J., Kuesel, A.C., A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis, 8(6), 2014, e2953.
46. [12] Baatjies, R., Meijster, T., Heederik, D., Sander, I., Jeebhay, M.F., Effectiveness of interventions to reduce flour dust exposures in supermarket bakeries in South Africa. Occup Environ Med 71 (2014), 811–818.
47. [13] Benn, C.S., Diness, B.R., Balde, I., Rodrigues, A., Lausch, K.R., Martins, C.L., et al. Two different doses of supplemental vitamin A did not affect mortality of normal-birth-weight neonates in Guinea-Bissau in a randomized controlled trial. J Nutr 144 (2014), 1474–1479.
48. [14] Betancourt, T.S., McBain, R., Newnham, E.A., Akinsulure-Smith, A.M., Brennan, R.T., Weisz, J.R., et al. A behavioral intervention for war-affected youth in Sierra Leone: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 53 (2014), 1288–1297.
49. [15] Bigna, J.J., Noubiap, J.J., Kouanfack, C., Plottel, C.S., Koulla-Shiro, S., Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial. Lancet Infect Dis 14 (2014), 600–608.
50. [16] Botha, U.A., Koen, L., Galal, U., Jordaan, E., Niehaus, D.J., The rise of assertive community interventions in South Africa: a randomized control trial assessing the impact of a modified assertive intervention on readmission rates; a three year follow-up. BMC Psychiatry, 14, 2014, 56.
51. [17] Boulware, D.R., Meya, D.B., Muzoora, C., Rolfes, M.A., Huppler Hullsiek, K., Musubire, A., et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 370 (2014), 2487–2498.
52. [18] Bruxvoort, K., Festo, C., Kalolella, A., Cairns, M., Lyaruu, P., Kenani, M., et al. Cluster randomized trial of text message reminders to retail staff in Tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence. Am J Trop Med Hyg 91 (2014), 844–853.
53. [19] Chagaluka, G., Stanley, C., Banda, K., Depani, S., Nijram'madzi, J., Katangwe, T., et al. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin. Eur J Cancer 50:8 (2014), 1472–1481.
54. [20] Chigbu, C.O., Onyebuchi, A.K., See-and-treat management of high-grade squamous intraepithelial lesions in a resource-constrained African setting. Int J Gynaecol Obstet 124 (2014), 204–206.
55. [21] Constant, D., Tolly, K., Harries, J., Myer, L., Mobile phone messages to provide support to women during the home phase of medical abortion in South Africa: a randomised controlled trial. Contraception 90 (2014), 226–233.
56. [22] Danno, K., Rerolle, F., de Sigalony, S., Colas, A., Terzan, L., Bordet, M.F., China rubra for side-effects of quinine: a prospective, randomised study in pregnant women with malaria in Cotonou, Benin. Homeopathy 103 (2014), 165–171.
57. [23] Deressa, W., Yihdego, Y.Y., Kebede, Z., Batisso, E., Tekalegne, A., Dagne, G.A., Effect of combining mosquito repellent and insecticide treated net on malaria prevalence in Southern Ethiopia: a cluster-randomised trial. Parasit Vectors, 7, 2014, 132.
58. [24] Desrochers, R.E., Siekmans, K., Berti, P.R., Bramhill, K., Buchan, S.A., Battah, G.K., et al. Effectiveness of post-campaign, door-to-door, hang-up, and communication interventions to increase long-lasting, insecticidal bed net utilization in Togo (2011-2012): A cluster randomized, control trial. Malar J, 13, 2014, 260.
59. [25] Djalle, D., Njuimo, S.P., Manirakiza, A., Laganier, R., Le Faou, A., Rogier, C., et al. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Malar J, 13, 2014, 9.
60. [26] Ezeama, C.O., Eleje, G.U., Ezeama, N.N., Igwegbe, A.O., Ikechebelu, J.I., Ugboaja, J.O., et al. A comparison of prophylactic intramuscular ergometrine and oxytocin for women in the third stage of labor. Int J Gynaecol Obstet 124 (2014), 67–71.
61. [27] Ezema, C.I., Onwunali, A.A., Lamina, S., Ezugwu, U.A., Amaeze, A.A., Nwankwo, M.J., et al. Effect of aerobic exercise training on cardiovascular parameters and CD4 cell count of people living with human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial. Niger J Clin Pract 17:5 (2014), 543–548.
62. [28] Eziefula, A.C., Bousema, T., Yeung, S., Kamya, M., Owaraganise, A., Gabagaya, G., et al. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis 14 (2014), 130–139.
63. [29] Falade, C.O., Dada-Adegbola, H.O., Ogunkunle, O.O., Oguike, M.C., Nash, O., Ademowo, O.G., Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo) for the treatment of acute uncomplicated malaria in Nigerian children. Med Princ Pract 23:3 (2014), 204–211.
64. [30] Fataki, M.R., Kisenge, R.R., Sudfeld, C.R., Aboud, S., Okuma, J., Mehta, S., et al. Effect of zinc supplementation on duration of hospitalization in Tanzanian children presenting with acute pneumonia. J Trop Pediatr 60 (2014), 104–111.
65. [31] Feikin, D.R., Bigogo, G., Audi, A., Pals, S.L., Aol, G., Mbakaya, C., et al. Village-randomized clinical trial of home distribution of zinc for treatment of childhood diarrhea in rural Western Kenya. PLoS One, 9, 2014, e94436.
66. [32] Fisker, A.B., Bale, C., Rodrigues, A., Balde, I., Fernandes, M., Jørgensen, M.J., et al. High-dose vitamin A with vaccination after 6 months of age: a randomized trial. Pediatrics 134 (2014), e739–e748.
67. [33] Flax, V.L., Bentley, M.E., Combs Jr, G.F., Chasela, C.S., Kayira, D., Tegha, G., et al. Plasma and breast-milk selenium in HIV-infected Malawian mothers are positively associated with infant selenium status but are not associated with maternal supplementation: results of the Breastfeeding, Antiretrovirals, and Nutrition study. Am J Clin Nutr 99 (2014), 950–956.
68. [34] Flax, V.L., Negerie, M., Ibrahim, A.U., Leatherman, S., Daza, E.J., Bentley, M.E., Integrating group counseling, cell phone messaging, and participant-generated songs and dramas into a microcredit program increases Nigerian women's adherence to international breastfeeding recommendations. J Nutr 144 (2014), 1120–1124.
69. [35] Fleischhacker, W.W., Sanchez, R., Perry, P.P., Jin, N., Peters-Strickland, T., Johnson, B.R., et al. Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study. Br J Psychiatry 205 (2014), 135–144.
70. [36] Fuchs, C.S., Tomasek, J., Yong, C.J., Dumitru, F., Passalacqua, R., Goswami, C., et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 383 (2014), 31–39.
71. [37] Gonzalez, R., Mombo-Ngo, G., Ouédraogo, S., Kakolwa, M.A., Abdulla, S., Accrombessima, M., et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med, 11(9), 2014, e1001733.
72. [38] Groome, M.J., Moon, S.S., Velasquez, D., Jones, S., Koen, A., van Niekerk, N., et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ 92 (2014), 238–245.
73. [39] Grossman, D., Constant, D., Lince-Deroche, N., Harries, J., Kluge, J., A randomized trial of misoprostol versus laminaria before dilation and evacuation in South Africa. Contraception 90 (2014), 234–241.
74. [40] Halliday, K.E., Okello, G., Turner, E.L., Njagi, K., Mcharo, C., Kengo, J., et al. Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial. PLoS Med, 11(1), 2014, e1001594.
75. [41] Hammitt, L.L., Ojal, J., Bashraheil, M., Morpeth, S.C., Karani, A., Habib, A., et al. Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial. PLoS One, 9, 2014, e85459.
76. [42] Harilall, Y., Adam, J.K., Biccard, B.M., Reddi, A., The effect of optimising cerebral tissue oxygen saturation on markers of neurological injury during coronary artery bypass graft surgery. Heart Lung Circ 23 (2014), 68–74.
77. [43] Ibinda, F., Mbuba, C.K., Kariuki, S.M., Chengo, E., Ngugi, A.K., Odhiambo, R., et al. Evaluation of Kilifi epilepsy education programme: a randomized controlled trial. Epilepsia 55 (2014), 344–352.
78. [44] Idehen, H.O., Amadasun, F.E., Ekwere, I.T., Comparison of intravenous colloid and colloid-crystalloid combination in hypotension prophylaxis during spinal anesthesia for cesarean section. Niger J Clin Pract 17:3 (2014), 309–313.
79. [45] Jacob, N., Neuner, F., Maedl, A., Schaal, S., Elbert, T., Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom 83 (2014), 354–363.
80. [46] Jemmott, I.J., Jemmott, L.S., Ngwane, Z., Zhang, J., Heeren, G.A., Icard, L.D., et al. Theory-based behavioral intervention increases self-reported physical activity in South African men: a cluster-randomized controlled trial. Prev Med 64 (2014), 114–120.
81. [47] Jindani, A., Harrison, T.S., Nunn, A.J., Phillips, P.P., Churchyard, G.J., Charalambous, S., et al. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med 371 (2014), 1599–1608.
82. [48] Johnson, J.L., Geldenhuy, H., Thiel, B.A, Toefy, A., Suliman, S., Pienaar, B., et al. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study. Chest 145 (2014), 612–617.
83. [49] Jones, D., Kashy, D., Chitalu, N., Kankasa, C., Mumbi, M., Cook, R., et al. Risk reduction among HIV-seroconcordant and -discordant couples: the Zambia NOW2 intervention. AIDS Patient Care STDS 28 (2014), 433–441.
84. [50] Joray, M.L., Yu, T.W., Ho, E., Clarke, S.L., Stanga, Z., Gebreegziabher, T., et al. Zinc supplementation reduced DNA breaks in Ethiopian women. Nutr Res 35:1 (2015), 49–55.
85. [51] Juan-Giner, A., Domicent, C., Langendorf, C., Roper, M.H., Baoundoh, P., Fermon, F., et al. A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain. Vaccine 32:47 (2014), 6220–6226.
86. [52] Malu, C.K.K., Kahamba, D.M., Walker, T.D., Mukampunga, C., Musalu, E.M., Kokolomani, J., et al. Efficacy of sublingual lorazepam versus intrarectal diazepam for prolonged convulsions in sub-Saharan Africa. J Child Neurol 29 (2014), 895–902.
87. [53] Keiser, J., Silue, K.D., Adiossan, L.K., N'Guessan, N.A., Monsan, N., Utzinger, J., et al. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial. PLoS Negl Trop Dis, 8(7), 2014, e2975.
88. [54] Keogh, S.C., Fry, K., Mbugua, E., Ayallo, M., Quinn, H., Otieno, G., et al. Vocal local versus pharmacological treatments for pain management in tubal ligation procedures in rural Kenya: a non-inferiority trial. BMC Womens Health, 14, 2014, 21.
89. [55] Khalil, E.A., Weldegebr, T., Younis, B.M., Omollo, R., Musa, A.M., Hailu, W., et al. Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. PLoS Negl Trop Dis, 8(1), 2014, e2613.
90. [56] Kiondo, P., Wamuyu-Maina, G., Wandabwa, J., Bimenya, GS., Tumwesigye, N.M., Okong, P., The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial. BMC Pregnancy Childbirth, 14, 2014, 283.
91. [57] Klement, E., Pitche, P., Kendjo, E., Singo, A., D'Almeida, S., Akouete, F., et al. Effectiveness of co-trimoxazole to prevent plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label randomized controlled trial. Clin Infect Dis 58 (2014), 651–659.
92. [58] Koegelenberg, C.F., Noor, F., Bateman, E.D., van Zyl-Smit, R.N., Bruning, A., O'Brien, J.A., et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA 312 (2014), 155–161.
93. [59] Kosiborod, M., Rasmussen, H.S., Lavin, P., Qunibi, W.Y., Spinowitz, N., Packham, D., et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA 312 (2014), 2223–2233.
94. [60] Kutamba, E., Mupere, E., Mugalu, J., Ouma, J., Mupere, E., Dextrose boluses versus burette dextrose infusions in prevention of hypoglycemia among preterms admitted at Mulago Hospital: an open label randomized clinical trial. Afr Health Sci 14 (2014), 502–509.
95. [61] L'Engle, K.L., Mwarogo, P., Kingola, N., Sinkele, W., Weiner, D.H., A randomized controlled trial of a brief intervention to reduce alcohol use among female sex workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 67 (2014), 446–453.
96. [62] Lund, S., Nielsen, B.B., Hemed, M., Boas, I.M., Said, A., Said, K., et al. Mobile phones improve antenatal care attendance in Zanzibar: a cluster randomized controlled trial. BMC Pregnancy Childbirth, 14, 2014, 29.
97. [63] MacPherson, P., Lalloo, D.G., Webb, E.L., Maheswaran, H., Choko, A.T., Makombe, S.D., et al. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA 312 (2014), 372–379.
98. [64] Madhi, S.A., Cutland, C.L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 371 (2014), 918–931.
99. [65] Maman, S., Moodley, D., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., et al. Efficacy of enhanced HIV counseling for risk reduction during pregnancy and in the postpartum period: a randomized controlled trial. PLoS One, 9, 2014, e97092.
100. [66] Manyando, C., Njunju, E.M., Mwakazanga, D., Chongwe, G., Mkandawire, R., Champo, D., et al. Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial. PLoS One, 9, 2014, e96017.
101. [67] Marrazzo, J.M., Ramjee, G., Richardson, B.A., Gomez, K., Mgodi, N., Nair, G., et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med 372 (2015), 509–518.
102. [68] Mbacham, W.F., Mangham-J, L., Cundill, B., Achonduh, O.A., Chandler, C.I., Ambebila, J.N., et al. Basic or enhanced clinician training to improve adherence to malaria treatment guidelines: a cluster-randomised trial in two areas of Cameroon. Lancet Glob Health 2:6 (2014), e346–e358.
103. [69] Mbada, C.E., Ayanniyi, O., Ogunlade, S.O., Orimolade, E.A., Oladiran, A.B., Ogundele, A.O., Influence of Mckenzie protocol and two modes of endurance exercises on health-related quality of life of patients with long-term mechanical low-back pain. Pan Afr Med J, 17(Suppl 1), 2014, 5.
104. [70] Merle, C.S., Fielding, K., Sow, O.B., Gninafon, M., Lo, M.B., Mthiyane, T., et al. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med 371 (2014), 1588–1598.
105. [71] Mertens, J.R., Ward, C.L., Bresick, G.F., Broder, T., Weisner, C.M., Effectiveness of nurse-practitioner-delivered brief motivational intervention for young adult alcohol and drug use in primary care in South Africa: a randomized clinical trial. Alcohol 49:4 (2014), 430–438.
106. [72] Mfinanga, S.G., Kirenga, B.J., Chanda, D.M., Mutayoba, B., Mthiyane, T., Yimer, G., et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis 14 (2014), 563–571.
107. [73] Michelson, D., Snyder, E., Paradis, E., Chengan-Liu, M., Snavely, D.B., Hutzelmann, J., et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 13 (2014), 461–471.
108. [74] Millard, P.S., Wilson, H.R., Goldstuck, N.D., Anaso, C., Rapid, minimally invasive adult voluntary male circumcision: a randomised trial of Unicirc, a novel disposable device. S Afr Med J 104:1 (2013), 52–57.
109. [75] Mivumbi, V.N., Little, S.E., Rulisa, S., Greenberg, J.A., Prophylactic ampicillin versus cefazolin for the prevention of post-cesarean infectious morbidity in Rwanda. Int J Gynaecol Obstet 124 (2014), 244–247.
110. [76] Molyneux, E.M., Kawaza, K., Phiri, A., Chimalizeni, Y., Mankhambo, L., Schwalbe, E., et al. Glycerol and acetaminophen as adjuvant therapy did not affect the outcome of bacterial meningitis in Malawian children. Pediatr Infect Dis J 33:2 (2014), 214–216.
111. [77] Mosha, T.C.E., Laswai, H.H., Assey, J., Bennink, M.R., Efficacy of a low-dose ferric-EDTA in reducing iron deficiency anaemia among under five children living in malaria-holoendemic district of mvomero, Tanzania. Tanzan J Health Res 16:2 (2014), 1–10.
112. [78] Muhumuza, S., Olsen, A., Katahoire, A., Kiragga, A.N., Nuwaha, F., Effectiveness of a pre-treatment snack on the uptake of mass treatment for schistosomiasis in Uganda: a cluster randomized trial. PLoS Med, 11(5), 2014, e1001640.
113. [79] Nankabirwa, J.I., Wandera, B., Amuge, P., Kiwanuka, N., Dorsey, G., Rosenthal, P.J., et al. Impact of intermittent preventive treatment with dihydroartemisinin- piperaquine on Malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis 58 (2014), 1404–1412.
114. [80] Nicol, A.J., Navsaria, P.H., Hommes, M., Ball, C.G., Edu, S., Kahn, D., Sternotomy or drainage for a hemopericardium after penetrating trauma: a randomized controlled trial. Ann Surg 259:3 (2014), 438–442.
115. [81] Nkengfack, G.N., Torimiro, J.N., Ngogang, J., Binting, S., Roll, S., Tinnemann, P., et al. Effects of an HIV-Care-Program on immunological parameters in HIV-positive patients in Yaounde, Cameroon: a cluster-randomized trial. Int J Public Health 59:3 (2014), 509–517.
116. [82] Ntagirabiri, R., Harerimana, S., Makuraza, F., Ndirahisha, E., Kaze, H., Moibeni, A., Helicobacter pylori au Burundi: première évaluation de la prévalence en endoscopie et de l’éradication. J Afr Hépatol Gastroentérol 8 (2014), 217–222.
117. [83] Oguche, S., Okafor, H.U., Watila, I., Meremikwu, M., Agomo, P., Ogala, W., et al. Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children. Am J Trop Med Hyg 91 (2014), 925–935.
118. [84] Ogutu, B.R., Onyango, K.O., Koskei, N., Omondi, E.K., Ongecha, J.M., Otieno, G.A., et al. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study. Malar J, 13, 2014, 33.
119. [85] Olaleye, O.A., Hamzat, T.K., Owolabi, M.O., Stroke rehabilitation: should physiotherapy intervention be provided at a primary health care centre or the patients' place of domicile?. Disabil Rehabil 36 (2014), 49–54.
120. [86] Olsen, M.F., Abdissa, A., Kæstel, P., Tesfaye, M., Yilma, D., Girma, T., et al. Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia. BMJ, 348, 2014, g3187.
121. [87] Onyamboko, M.A., Fanello, C.I., Wongsaen, K., Tarning, J., Cheah, P.Y., Tshefu, K.A., et al. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo. Antimicrob Agents Chemother 58 (2014), 5528–5536.
122. [88] Osoti, A.O., John-Stewart, G., Kiarie, J., Richardson, B., Kinuthia, J., Krakowiak, D., et al. Home visits during pregnancy enhance male partner HIV counselling and testing in Kenya: a randomized clinical trial. AIDS 28 (2014), 95–103.
123. [89] Paton, N.I., Kityo, C., Hoppe, A., Reid, A., Kambugu, A., Lugemwa, A., et al. Assessment of second-line antiretroviral regimens for HIV therapy in Africa. N Engl J Med 371 (2014), 234–247.
124. [90] Penfold, S., Manzi, F., Mkumbo, E., Temu, S., Jaribu, J., Shamba, D.D., et al. Effect of home-based counselling on newborn care practices in southern Tanzania one year after implementation: a cluster-randomised controlled trial. BMC Pediatr, 14, 2014, 187.
125. [91] Petry, N., Egli, I., Gahutu, J.B., Tugirimana, P.L., Boy, E., Hurrell, R., Phytic acid concentration influences iron bioavailability from biofortified beans in Rwandese women with low iron status. J Nutr 144 (2014), 1681–1687.
126. [92] Polis, C.B., Nakigozi, G.F., Nakawooya, H., Mondo, G., Makumbi, F., Gray, R.H., et al. Preference for Sayana Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial. Contraception 89 (2014), 385–395.
127. [93] Price, T.J., Peeters, M., Kim, T.W., Li, J., Cascinu, S., Ruff, P., et al. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol 15 (2014), 569–579.
128. [94] ENCORE1 Study Group, Puls, R., Amin, J., Losso, M., Phanuphak, P., Nwizu, C., Orrell, C., et al. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet 383 (2014), 1474–1482.
129. [95] Raal, F.J., Honarpour, N., Blom, D.J., Hovingh, G.K., Xu, F., Scott, R., Wasserman, S.M., et al. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial. Lancet 385 (2015), 341–350.
130. [96] Raal, F.J., Stein, E.A., Dufour, R., Turner, T., Civeira, F., Burgess, L., et al. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet 385 (2015), 331–340.
131. [97] Raifman, J.R.G., Lanthorn, H.E., Rokicki, S., Fink, G., The impact of text message reminders on adherence to antimalarial treatment in northern Ghana: a randomized trial. PLoS One, 9, 2014, e109032.
132. [98] Rangaka, M.X., Wilkinson, R.J., Boulle, A., Glynn, J.R., Fielding, K., van Cutsem, G., et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet 384 (2014), 682–690.
133. [99] Reck, M., Kaiser, R., Mellemgaard, A., Douillard, J.Y., Orlov, S., Krzakowski, M., et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 15 (2014), 143–155.
134. [100] Reznik, Y., Cohen, O., Aronson, R., Conget, I., Runzis, S., Castaneda, J., et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet 384 (2014), 1265–1272.
135. [101] Richter, L., Rotheram-Borus, M.J., Van Heerden, A., Stein, A., Tomlinson, M., Harwood, J.M., et al. Pregnant women living with HIV (WLH) supported at clinics by peer WLH: a cluster randomized controlled trial. AIDS Behav 18 (2014), 706–715.
136. [102] Rosa, G., Majorin, F., Boisson, S., Barstow, C., Johnson, M., Kirby, M., et al. Assessing the impact of water filters and improved cook stoves on drinking water quality and household air pollution: a randomised controlled trial in Rwanda. PLoS One, 9, 2014, e91011.
137. [103] Ryan, K.N., Stephenson, K.B., Trehan, I., Shulman, R.J., Thakwalakwa, C., Murray, E., et al. Zinc or albendazole attenuates the progression of environmental enteropathy: a randomized controlled trial. Clin Gastroenterol Hepatol 12:9 (2014), 1507–1513.e1.
138. [104] Shekalaghe, S., Rutaihwa, M., Billingsley, P.F., Chemba, M., Daubenberger, C.A., James, E.R., et al. Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg 91 (2014), 471–480.
139. [105] Sjouke, B., Langslet, G., Ceska, R., Nicholls, S.J., Nissen, S.E., Öhlander, M., et al. Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. Lancet Diabetes Endocrinol 2 (2014), 455–463.
140. [106] Sokal, D.C., Li, P.S., Zulu, R., Awori, Q.D., Combes, S.L., Simba, R.O., et al. Randomized controlled trial of the shang ring versus conventional surgical techniques for adult male circumcision: safety and acceptability. J Acquir Immune Defic Syndr 65 (2014), 447–455.
141. [107] Sossauer, G., Zbinden, M., Tebeu, P.M., Fosso, G.K., Untiet, S., Vassilakos, P., et al. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon. PLoS One, 9, 2014, e109788.
142. [108] Speich, B., Ame, S.M., Ali, S.M., Alles, R., Huwyler, J., Hattendorf, J., et al. Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med 370 (2014), 610–620.
143. [109] Sumner, S.A., Pallangyo, A.J., Reddy, E.A., Maro, V., Pence, B.W., Lynch, C., et al. Effect of free distribution of safety equipment on usage among motorcycle-taxi drivers in Tanzania—a cluster randomised controlled trial. Injury 45 (2014), 1681–1686.
144. [110] Sundy, J.S., Schumache, H.R., Kivitz, A., Weinstein, S.P., Wu, R, King-Davis, S., et al. Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study. J Rheumatol 41 (2014), 1703–1711.
145. [111] Thacher, T.D., Fischer, P.R., Pettifor, J.M., Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial. Arch Dis Child 99 (2014), 807–811.
146. [112] Thakwalakwa, C., Phiri, A., Rollins, N., Heikens, G.T., Barnell, E.K., Manary, M., et al. Growth and HIV-free survival of HIV-exposed infants in Malawi: a randomized trial of two complementary feeding interventions in the context of maternal antiretroviral therapy. J Acquir Immune Defic Syndr 66 (2014), 181–187.
147. [113] Tinto, H., Diallo, S., Zongo, I., Guiraud, I., Valea, I., Kazienga, A., et al. Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Trop Med Int Health 19 (2014), 469–475.
148. [114] Tiono, A.B., Kangoye, D.T., Rehman, A.M., Kargougou, D.G., Kaboré, Y., Diarra, A., et al. Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods. PLoS One, 9, 2014, e86936.
149. [115] Tol, W.A., Komproe, I.H., Jordans, M.J., Ndayisaba, A., Ntamutumba, P., Sipsma, H., et al. School-based mental health intervention for children in war-affected Burundi: a cluster randomized trial. BMC Med, 12, 2014, 56.
150. [116] Tomlinson, M., Doherty, T., Ijumba, P., Jackson, D., Lawn, J., Persson, L.A., et al. Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township. Trop Med Int Health 19 (2014), 256–266.
151. [117] Ugwu, E.O., Obi, S.N., Iferikigwe, E.S., Dim, C.C., Ezugwu, F.O., Membrane stripping to prevent post-term pregnancy in Enugu, Nigeria: a randomized controlled trial. Arch Gynecol Obstet 289:1 (2014), 29–34.
152. [118] West, P.A., Protopopoff, N., Wright, A., Kivaju, Z., Tigererwa, R., Mosha, F.M, et al. Indoor residual spraying in combination with insecticide-treated nets compared to insecticide-treated nets alone for protection against malaria: a cluster randomised trial in Tanzania. PLoS Med, 11(4), 2014, e1001630.
153. [119] Westen, E.H., Kolk, P.R., van Velzen, C.L., Unkels, R., Mmuni, N.S., Hamisi, A.D., et al. Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial. Acta Obstet Gynecol Scand 94:1 (2015), 43–49.
154. [120] Yan, H., Prista, A., Ranadive, S.M., Damasceno, A., Caupers, P., Kanaley, J.A., et al. Effect of aerobic training on glucose control and blood pressure in T2DDM East African males. ISRN Endocrinol, 2014, 2014, 864897.
155. [121] Yeka, A., Lameyre, V., Afizi, K., Fredrick, M., Lukwago, R., Kamya, M.R., et al. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. PLoS One, 9, 2014, e113311.